EXPLORE CONNECTIONS
Glycoengineering of NK cells with glycan ligands of CD22 and selectins for B-cell lymphoma therapy
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.